Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM)-Reference-Cited by-同舟云学术

Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM)

Published:2004-02 Issue:2 Volume:63 Page:309-313
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Roobol M.J,Kranse R,de Koning H.J,Schröder F.H

Publisher

Elsevier BV

Subject

Urology

Reference13 articles.

1. Cancer statistics;Landis;Cancer J Clin,1999

2. Trends of Cancer in The Netherlands 1989–1998;Van Dijck,2002

3. Prostate cancer detection at low prostate specific antigen;Schröder;J Urol,2000

4. Diagnosis, characterization and potential clinical relevance of prostate cancer detected at low PSA ranges;Schröder;Eur Urol,2001

5. Prostate specific antigen based early detection of prostate cancer—validation of screening without rectal examination;Schröder;Urology,2001

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UPDATE – 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis: Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging;Canadian Urological Association Journal;2022-03-31

2. Personalized strategies in population screening for prostate cancer;International Journal of Cancer;2020-06-03

3. Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review;Oncology Reviews;2020-05-04

4. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition;British Journal of Cancer;2018-01

5. Canadian Urological Association recommendations on prostate cancer screening and early diagnosis;Canadian Urological Association Journal;2017-10-12